Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030

Advances in the fields of cell biology and regenerative medicine have led to the development of various cell-based therapies, which, developers claim, possess the potential to treat a variety of clinical conditions. In 2018, it was reported that there were more than 1,000 clinical trials of such therapies, being conducted across the globe by over 900 industry players. Moreover, the total investment in the aforementioned clinical research efforts was estimated to be around USD 13 billion. Given the recent breakthroughs in clinical testing and the discovery of a variety of diagnostic biomarkers, the isolation of one or multiple cell types from a heterogenous population has not only become simpler but also an integral part of modern clinical R&D. The applications of cell separation technologies are vast, starting from basic research to biological therapy development and manufacturing. However, conventional cell sorting techniques, including adherence-based sorting, membrane filtration-based sorting, and fluorescence- and magnetic-based sorting, are limited by exorbitant operational costs, time-consuming procedures, and the need for complex biochemical labels. As a result, the use of such techniques has, so far, been restricted in the more niche and emerging application areas.

Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating cells from tissue samples and/or heterogeneous cell populations. In fact, since 2014, over 3,000 patents were reported to have been filed/granted related to such advanced techniques, indicating the rapid pace of innovation in this domain. Developers of the aforementioned technologies claim that these new techniques offer numerous benefits, including fast and precise cell sorting, reduced sample requirement, improved portability, reduced risk to cell viability, and negligible need for expensive biochemical/magnetic labels. Moreover, they have been shown to be compatible for use across a myriad of applications, including research studies (bacteriology, immunology, stem cell research, and viral titering and infectivity), biomedical diagnostics (circulating tumor cell detection, in vitro fertilization, and non-invasive prenatal diagnosis), biological therapy-related process operations (bio-banking, drug discovery, sample preparation, single-cell sequencing, and tumor cell characterization), and cell-based therapeutics (B- or T-cell immunotherapies). Consequently, these techniques have captured the interest of several stakeholders in the biopharmaceutical industry. It is also worth highlighting that stakeholders in this domain have received significant support from both private and public investors.

Scope of the Report

The ‘Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity, and Other Technologies, 2019-2030’ report features an extensive study of the current landscape and future outlook of the growing market for novel cell sorting and separation technologies (beyond conventional methods). The study presents detailed analyses of cell sorters, cell isolation kits, and affiliated consumables and reagents, that are based on the aforementioned technologies. Amongst other elements, the report features:

A detailed assessment of the current market landscape, featuring a comprehensive list of over 220 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with information on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, immune cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end-use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics).
An insightful company competitiveness analysis, taking into consideration the supplier power (based on size of employee base and experience in this segment of the industry) and portfolio-related parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s).
Comprehensive profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are currently offering novel cell sorters/consumables and cell isolation kits, featuring an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth in the foreseen future.
An in-depth analysis of the patents that have been filed/granted related to novel cell sorting and separation technologies, since 2014. It highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed/granted), and current intellectual property-related benchmarks and valuation.
Detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analysis based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain.
An analysis of the partnerships that have been established in the domain, in the period 2014-Q1 2019, covering R&D collaborations, licensing agreements, distribution agreements, mergers/acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and other relevant deals.
An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants/awards, capital raised from IPOs and subsequent offerings, by companies that are engaged in this field.
An analysis to estimate the likely demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in different global regions for the period 2019-2030.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the novel cell sorting and separation market. Based on multiple parameters, such as potential application areas, likely adoption rate, and expected pricing, we have provided an informed estimate on the likely evolution of the market, over the period 2019-2030. In addition, we have provided the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 µm, 5-10 µm, 10-15 µm, 15-25 µm, and > 25 µm), and [G] key geographical regions (North America, Europe and Asia-Pacific). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of organization names)

John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences)
Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte)
Soohee Cho (Product Manager, Namocell)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD unless otherwise specified.

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Context and Background
3.2. Introduction to Cell Sorting and Separation
3.2.1. Historical Overview
3.2.2. Basic Components and Principle of Operation
3.2.3. Cellular Characteristics Considered for Cell Sorting and Separation
3.2.3.1. Cell Size and Density
3.2.3.2. Hydrodynamic Properties
3.2.3.3. Polarizability, Electrical Impedance and Magnetic Susceptibility
3.2.3.4. Surface Charge and Adhesion
3.2.4. Conventional Cell Sorting and Separation Methods
3.2.4.1. Adhesion-based Sorting
3.2.4.2. Density Gradient Centrifugation Sorting
3.2.4.3. Fluorescence-activated Sorting
3.2.4.4. Magnetic-activated Sorting
3.2.4.5. Membrane Filtration Sorting
3.2.5. Limitations of Conventional Cell Sorting and Separation Methods
3.3. Novel Cell Sorting and Separation Technologies
3.3.1. Buoyancy-activated Sorting
3.3.2. Microfluidics-based Sorting
3.3.2.1. Microfluidics-based Active Sorting Technologies
3.3.2.1.1. Acoustic Sorting
3.3.2.1.2. Aqueous Two-Phase Sorting
3.3.2.1.3. Electrophoretic Sorting
3.3.2.1.4. Magnetic Levitation-based Sorting
3.3.2.1.5. Optoelectronics-based Sorting
3.3.2.2. Microfluidics-based Passive Sorting Technologies
3.3.2.2.1. Biomimetic Sorting
3.3.2.2.2. Deterministic Lateral Displacement Sorting
3.3.2.2.3. Field Flow Fractionation Sorting
3.3.2.2.4. Gravity and Sedimentation Sorting
3.3.2.2.5. Hydrodynamic Sorting
3.3.2.2.6. Inertia-based Sorting
3.3.2.2.7. Microfiltration Sorting
3.3.2.2.8. Microstructures-based Sorting
3.3.3. Other Types of Cell Sorting and Separation Technologies
3.3.3.1. Density Difference Amplification-based Sorting
3.3.3.2. SpheriTech Purification and Sorting
3.3.3.3. Traceless Affinity-based Sorting
3.4. Key Applications of Novel Cell Sorting and Separation Technologies
3.4.1. Clinical Research
3.4.2. Biomedical Diagnostics
3.4.3. Cell-based Therapeutics
3.5. Growth Drivers and Roadblocks
3.6. Recent Developments and Upcoming Trends

4. CURRENT MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Novel Cell Sorting Products and Solutions: Overall Market Landscape
4.2.1. Analysis by Type of Product
4.2.2. Analysis by Basis for Separation
4.2.3. Analysis by Type of Technology
4.2.4. Analysis by Cell Separation Approach
4.2.5. Analysis by Type of Cell
4.3. Novel Cell Sorting Products and Solutions: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Location of Headquarters
4.3.3. Analysis by Size of Company
4.3.4. Analysis by Type of Offering
4.3.5. Analysis by End Use / Application
4.3.6. Leading Developers: Analysis by Number of Products
4.3.7. Grid Analysis by Company Size, Type of Offering and End Use / Application

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Parameters
5.4. Novel Cell Sorting Products and Solutions Providers: Company Competitiveness Analysis
5.4.1. Small-sized Companies
5.4.2. Mid-sized Companies
5.4.3. Large Companies

6. PROFILES: COMPANIES OFFERING NOVEL CELL SORTERS / SORTING TECHNOLOGIES

6.1. Chapter Overview
6.2. NanoCellect Biomedical
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. WOLF® Cell Sorter, N1® Single Cell Dispenser: Product Description
6.2.4. Recent Developments and Future Outlook
6.3. Innovative Biochips
6.3.1. Company Overview
6.3.2 Financial Information
6.3.3. SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION, SMART ALIQUOTOR EXTENDED EDITION: Product Description
6.3.4. Recent Developments and Future Outlook
6.4. Cesca Therapeutics
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. AUTOXPRESS®, CAR-TXPRESS™, CELLXPRESS™: Product Description
6.4.4. Recent Developments and Future Outlook
6.5. Fluidigm
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. C1™ System: Product Description
6.5.4. Recent Developments and Future Outlook
6.6. LumaCyte
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Radiance™: Product Description
6.6.4. Recent Developments and Future Outlook
6.7. Union Biometrica
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. COPAS™ FP, BioSorter®: Product Description
6.7.4. Recent Developments and Future Outlook
6.8. LevitasBio
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. LeviCell System: Product Description
6.8.4. Recent Developments and Future Outlook
6.9. RareCyte®
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. AccuCyte® Sample Preparation System: Product Description
6.9.4. Recent Developments and Future Outlook
6.10. Cytonome
6.10.1. Cytonome Viva™, Cytonome Hydris™, Cytonome GigaSort™: Product Description
6.10.2. Recent Developments and Future Outlook
6.11. Namocell
6.11.1. Namo™ Single Cell Dispenser, Hana™ Single Cell Dispenser: Product Description
6.11.2. Recent Developments and Future Outlook

7. PROFILES: COMPANIES OFFERING NOVEL CONSUMABLES AND ISOLATION KITS

7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Akadeum Life Sciences
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. QIAGEN
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Product Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. RareCyte®
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Product Portfolio
7.5.4. Recent Developments and Future Outlook
7.6. ScreenCell
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook

8. PATENT ANALYSIS

8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Novel Cell Sorting Products and Solutions: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Geographical Location
8.3.3 Analysis by CPC Symbols
8.3.4. Emerging Focus Areas
8.3.5. Leading Players: Analysis by Number of Patents
8.4. Novel Cell Sorting Products and Solutions: Patent Benchmarking Analysis (Industry Players)
8.4.1. Analysis by Patent Characteristics
8.4.2. Analysis by Geographical Location
8.5. Novel Cell Sorting Products and Solutions: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations

9. PUBLICATION ANALYSIS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Novel Cell Sorting Products and Solutions: Publication Analysis
9.3.1. Analysis by Year of Publication
9.3.2. Emerging Focus Areas
9.3.3. Analysis by Cell Sorting Technology
9.3.4. Analysis by Application Area
9.3.5. Analysis by Type of Cell
9.3.6. Analysis by Target Disease Indication
9.3.7. Analysis by Type of Organization Involved
9.3.8. Leading Players: Analysis by Number of Publications
9.3.9. Leading Players: Geographical Analysis by Number of Publications
9.3.10. Key Journals: Analysis by Number of Publications

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Novel Cell Sorting Products and Solutions: Recent Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Cell Sorting Technology
10.3.4. Analysis by Type of Partner
10.3.5. Most Active Players: Analysis by Number of Partnerships
10.3.6. Geographical Analysis
10.3.6.1. Most Active Players
10.3.6.2. Intercontinental and Intracontinental Agreements

11. FUNDING AND INVESTMENT ANALYSIS

11.1. Chapter Overview
11.2. Types of Funding
11.3. Novel Cell Sorting Products and Solutions: Recent Funding Instances
11.3.1. Analysis by Number of Funding Instances
11.3.2. Analysis by Amount Invested
11.3.3. Analysis by Type of Funding
11.3.4. Analysis by Number of Funding Instances and Amount Invested across Different Cell Sorting Technologies
11.3.5. Most Active Players: Analysis by Number of Funding Instances
11.3.6. Most Active Players: Analysis by Amount Invested
11.3.7. Most Active Investors: Analysis by Number of Instances
11.3.8. Geographical Analysis by Amount Invested
11.4. Concluding Remarks

12. DEMAND ANALYSIS

12.1. Chapter Overview
12.2 Key Assumptions and Methodology
12.3. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030
12.3.1. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
12.3.1.1. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030
12.3.1.2. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030
12.3.1.3. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030
12.3.1.4. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030
12.3.1.5. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030
12.3.2. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by Geography and End Use / Application
12.3.2.1. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030
12.3.2.1.1. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030
12.3.2.1.2. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030
12.3.2.1.3. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030
12.3.2.1.4. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030
12.3.2.1.5. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030
12.3.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030
12.3.2.2.1. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030
12.3.2.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030
12.3.2.2.3. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030
12.3.2.2.4. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030
12.3.2.2.5. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030
12.3.2.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030
12.3.2.3.1. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030
12.3.2.3.2. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030
12.3.2.3.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030
12.3.2.3.4. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030
12.3.2.3.5. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030

13. MARKET FORECAST

13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Overall Novel Cell Sorting Products and Solutions Market
13.3.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Value)
13.3.2 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Volume)
13.4. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering
13.4.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Value)
13.4.1.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Value)
13.4.1.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Value)
13.4.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Volume)
13.4.2.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Volume)
13.4.2.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Volume)
13.5. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application
13.5.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Value)
13.5.1.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Value)
13.5.1.2. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.5.1.3. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (By Value)
13.5.1.4. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.5.1.5. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.5.2. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Volume)
13.5.2.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Volume)
13.5.2.2. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.5.2.3. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (By Volume)
13.5.2.4. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.5.2.5. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology
13.6.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Value)
13.6.1.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Value)
13.6.1.2. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (By Value)
13.6.1.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Value)
13.6.1.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Value)
13.6.1.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Value)
13.6.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Volume)
13.6.2.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Volume)
13.6.2.2. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (By Volume)
13.6.2.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Volume)
13.6.2.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Volume)
13.6.2.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Volume)
13.7. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell
13.7.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Value)
13.7.1.1. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (By Value)
13.7.1.2. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (By Value)
13.7.1.3. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (By Value)
13.7.1.4. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Value)
13.7.1.5. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (By Value)
13.7.1.6. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (By Value)
13.7.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Volume)
13.7.2.1. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (By Volume)
13.7.2.2. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (By Volume)
13.7.2.3. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (By Volume)
13.7.2.4. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Volume)
13.7.2.5. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (By Volume)
13.7.2.6. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (By Volume)
13.8. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography
13.8.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Value)
13.8.1.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Value)
13.8.1.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Value)
13.8.1.3 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Value)
13.8.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Volume)
13.8.2.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Volume)
13.8.2.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Volume)
13.8.2.3. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Volume)
13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application Cell Sorting Technology and Type of Offering
13.9.1. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.1.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.9.1.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.2.1. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.9.1.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.9.1.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.9.1.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Value)
13.9.1.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
13.9.1.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
13.9.2. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.2.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
13.9.2.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.2.1. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
13.9.2.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
13.9.2.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
13.9.2.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
13.9.2.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
13.9.2.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
13.9.3. Overall Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.3.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.1.1. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.2.1. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.3.1. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.3.2. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.4.1. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.5.1. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.3.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
13.9.4. Overall Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.4.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.1.1. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.2.1. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.3.1. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.3.2. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.4.1. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.5.1. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.4.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
13.9.5. Overall Novel Cell Sorting Products and Solutions Market for In vitro Fertilization: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.5.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.1.1. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.1.2. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.2.1. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.3.1. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.3.2. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.4.1. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.4.2. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.5.1. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.5.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
13.9.6. Overall Novel Cell Sorting Products and Solutions Market for In vitro Fertilization: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.6.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.1.1. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.1.2. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.2.1. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.3.1. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.3.2. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.4.1. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.4.2. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.5.1. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.6.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
13.9.7. Overall Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.7.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.1.1. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.2.1. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.3.1. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.3.2. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.4.1. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.5.1. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.7.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
13.9.8. Overall Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.8.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.1.1. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.2.1. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.3.1. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.3.2. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.4.1. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.5.1. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.8.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
13.9.9. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Value)
13.9.9.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.2.1. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.9.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
13.9.10. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
13.9.10.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.2.1. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
13.9.10.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)

14. EXECUTIVE INSIGHTS

14.1. Chapter Overview
14.2. Akadeum Life Sciences
14.2.1. Company Snapshot
14.2.2. Interview Transcript: John Younger, Co-founder and Chief Technology Officer
14.3. LumaCyte
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Sean Hart, Chief Executive Officer and Chief Scientific Officer
14.4. Namocell
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Soohee Cho, Product Manager

15. CONCLUDING REMARKS

15.1. Chapter Overview
15.2. Key Takeaways

16. APPENDIX 1: TABULATED DATA17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

Figure 3.1. Basic Components of a Cell Sorter
Figure 3.2. Limitations of Conventional Cell Sorting and Separation Methods
Figure 3.3. Classification of Novel Cell Sorting and Separation Technologies
Figure 3.4. Advantages and Challenges of Buoyancy-activated Cell Sorting
Figure 3.5. Advantages and Challenges of Microfluidics-based Cell Sorting
Figure 3.6. Key Applications of Novel Cell Sorting and Separation Technologies
Figure 3.7. Growth Drivers and Roadblocks to Novel Cell Sorting and Separation Technologies
Figure 3.8. Recent Developments and Upcoming Trends Related to Novel Cell Sorting and Separation Technologies
Figure 4.1. Novel Cell Sorting Products and Solutions: Distribution by Type of Product
Figure 4.2. Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
Figure 4.3. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell Sorting Technology
Figure 4.4. Novel Cell Sorting Products and Solutions: Logo Landscape of Developers by Type of Cell Sorting Technology
Figure 4.5. Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
Figure 4.6. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
Figure 4.7. Popular Cell Types: Distribution by Number of Products
Figure 4.8. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
Figure 4.9. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
Figure 4.10. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
Figure 4.11. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
Figure 4.12. Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
Figure 4.13. Leading Developers: Distribution by Number of Products
Figure 4.14. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size, Type of Offering and End Use / Application
Figure 5.1. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
Figure 5.2. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
Figure 5.3. Competitiveness Analysis of Large Novel Cell Sorting Products and Solutions Providers
Figure 8.1. Patent Analysis: Distribution by Type
Figure 8.2. Patent Analysis: Cumulative Year-wise Trend, 2014-2018
Figure 8.3. Patent Analysis: Distribution by Geographical Location
Figure 8.4. Patent Analysis: Distribution by CPC Symbols (Top 20)
Figure 8.5. Patent Analysis: Emerging Focus Areas
Figure 8.6. Most Active Industry Players: Distribution by Number of Patents
Figure 8.7. Most Active Non-Industry Players: Distribution by Number of Patents
Figure 8.8. Patent Analysis: Benchmarking by Patent Characteristics
Figure 8.9. Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
Figure 8.10. Patent Analysis: Benchmarking by Number of International Patents
Figure 8.11. Patent Analysis: Distribution by Patent Age, 2014-2018
Figure 8.12. Patent Analysis: Distribution by Geography and Year of Publication, 2014-2018
Figure 8.13. Patent Analysis: Distribution by Relative Valuation
Figure 9.1. Publication Analysis: Cumulative Year-wise Trend, 2014-2018
Figure 9.2. Publication Analysis: Emerging Focus Areas
Figure 9.3. Publication Analysis: Distribution by Cell Sorting Technology
Figure 9.4. Publication Analysis: Distribution by End Use / Application Area
Figure 9.5. Publication Analysis: Distribution by Type of Cell
Figure 9.6. Publication Analysis: Distribution by Target Disease Indication
Figure 9.7. Publication Analysis: Distribution by Type of Organization Involved
Figure 9.8. Most Active Players: Distribution by Number of Publications
Figure 9.9. Most Active Players: Geographical Distribution by Number of Publications
Figure 9.10. Key Journals: Distribution by Number of Publications
Figure 10.1. Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
Figure 10.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3. Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 10.4. Partnerships and Collaborations: Distribution by Cell Sorting Technology
Figure 10.5. Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
Figure 10.6. Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.7. Most Active Players: Distribution by Number of Partnerships
Figure 10.8. Most Active Players: Geographical Distribution by Number of Partnerships
Figure 10.9. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 11.1. Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
Figure 11.2. Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
Figure 11.3. Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
Figure 11.4. Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
Figure 11.5. Funding and Investments: Distribution by Type of Funding
Figure 11.6. Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
Figure 11.7. Funding and Investments: Summary of Investments, 2014-Q1 2019 (USD Million)
Figure 11.8. Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
Figure 11.9. Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
Figure 11.10. Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
Figure 11.11. Most Active Players: Distribution by Number of Instances
Figure 11.12. Most Active Players: Distribution by Capital Amount Raised (USD Million)
Figure 11.13. Most Active Investors: Distribution by Number of Instances
Figure 11.14. Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
Figure 11.15. Funding and Investment Summary
Figure 12.1. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Units)
Figure 12.2. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 12.3. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.4. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.5. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030 (Million Units)
Figure 12.6. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 12.7. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Units)
Figure 12.8. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Units)
Figure 12.9. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.10. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.11. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 12.12. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 12.13. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Units)
Figure 12.14. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Units)
Figure 12.15. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.16. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.17. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 12.18. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 12.19. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Units)
Figure 12.20. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Units)
Figure 12.21. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 12.22. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030 (Million Units)
Figure 12.23. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 12.24. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 13.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (USD Million)
Figure 13.2. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (Million Units)
Figure 13.3. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (USD Million)
Figure 13.4. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (USD Million)
Figure 13.5. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (USD Million)
Figure 13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (Million Units)
Figure 13.7. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (Million Units)
Figure 13.8. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (Million Units)
Figure 13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (USD Million)
Figure 13.10. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (USD Million)
Figure 13.11. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.12. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 13.13. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 13.14. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 13.15. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (Million Units)
Figure 13.16. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (Million Units)
Figure 13.17. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 13.18. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 13.19. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 13.20. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 13.21. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (USD Million)
Figure 13.22. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (USD Million)
Figure 13.23. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (USD Million)
Figure 13.24. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (USD Million)
Figure 13.25. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (USD Million)
Figure 13.26. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (USD Million)
Figure 13.27. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (Million Units)
Figure 13.28. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (Million Units)
Figure 13.29. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (Million Units)
Figure 13.30. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (Million Units)
Figure 13.31. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (Million Units)
Figure 13.32. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (Million Units)
Figure 13.33. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (USD Million)
Figure 13.34. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (USD Million)
Figure 13.35. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (USD Million)
Figure 13.36. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (USD Million)
Figure 13.37. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (USD Million)
Figure 13.38. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (USD Million)
Figure 13.39. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (USD Million)
Figure 13.40. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (Million Units)
Figure 13.41. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (Million Units)
Figure 13.42. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (Million Units)
Figure 13.43. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (Million Units)
Figure 13.44. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (Million Units)
Figure 13.45. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (Million Units)
Figure 13.46. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (Million Units)
Figure 13.47. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (USD Million)
Figure 13.48. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (USD Million)
Figure 13.49. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (USD Million)
Figure 13.50. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (USD Million)
Figure 13.51. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (Million Units)
Figure 13.52. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (Million Units)
Figure 13.53. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (Million Units)
Figure 13.54. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (Million Units)
Figure 13.55. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.56. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.57. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.58. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.59. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.60. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.61. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.62. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.63. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.64. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.65. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.66. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.67. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
Figure 13.68. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
Figure 13.69. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
Figure 13.70. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.71. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.72. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.73. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.74. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.75. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.76. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.77. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.78. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.79. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.80. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.81. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.82. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
Figure 13.83. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
Figure 13.84. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
Figure 13.85. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.86. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.87. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.88. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.89. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.90. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.91. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.92. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.93. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.94. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.95. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.96. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.97. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.98. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 13.99. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
Figure 14.100. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.101. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.102. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.103. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.104. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.105. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.106. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.107. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.108. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.109. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.110. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.111. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.112. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.113. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.114. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Figure 14.115. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.116. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.117. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.118. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.119. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.120. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.121. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.122. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.123. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.124. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.125. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.126. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.127. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.128. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.129. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
Figure 14.130. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.131. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.132. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.133. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.134. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.135. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.136. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.137. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.138. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.139. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.140. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.141. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.142. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.143. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.144. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
Figure 14.145. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.146. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.147. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.148. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.149. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.150. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.151. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.152. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.153. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.154. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.155. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.156. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.157. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.158. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.159. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
Figure 14.160. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.161. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.162. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.163. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.164. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.165. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.166. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.167. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.168. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.169. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.170. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.171. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.172. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.173. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.174. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Figure 14.175. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.176. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.177. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.178. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.179. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.180. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.181. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.182. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.183. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.184. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.185. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.186. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.187. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.188. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.189. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
Figure 14.190. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.191. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.192. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.193. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.194. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.195. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.196. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.197. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.198. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.199. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.200. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.201. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.202. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.203. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
Figure 14.204. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)

List of Tables

Table 3.1. Conventional Flow Cytometers
Table 3.2. Microfluidics-based Cell Sorting Technologies
Table 4.1. Novel Cell Sorting Products and Solutions: Information on Type of Product, Cell Sorting Technology and Type of Cell
Table 4.2. Novel Cell Sorting Products and Solutions: Information on Cell Separation Approach, Basis for Separation and End Use / Application
Table 4.3. Novel Cell Sorting Products and Solutions: Information on Key Specifications
Table 4.4. Novel Cell Sorting Products and Solutions: Developer Overview
Table 5.1. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
Table 5.2. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
Table 5.3. Competitiveness Analysis of Large-sized Novel Cell Sorting Products and Solutions Providers
Table 6.1. NanoCellect Biomedical: Key Highlights
Table 6.2. NanoCellect Biomedical: Funding Instances
Table 6.3. NanoCellect Biomedical: Key Characteristics of WOLF® Cell Sorter and N1® Single Cell Dispenser
Table 6.4. NanoCellect Biomedical: Recent Developments and Future Outlook
Table 6.5. Innovative Biochips: Key Highlights
Table 6.6. Innovative Biochips: Funding Instances
Table 6.7. Innovative Biochips: Key Characteristics of SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION and SMART ALIQUOTOR EXTENDED EDITION
Table 6.8. Recent Developments and Future Outlook
Table 6.9. Cesca Therapeutics: Key Highlights
Table 6.10. Cesca Therapeutics: Funding Instances
Table 6.11. Cesca Therapeutics: Key Characteristics of AUTOXPRESS®, CAR-TXPRESS™ and CELLXPRESS™
Table 6.12. Recent Developments and Future Outlook
Table 6.13. Fluidigm: Key Highlights
Table 6.14. Fluidigm: Funding Instances
Table 6.15. Fluidigm: Key Characteristics of C1™ System
Table 6.16. Fluidigm: Recent Developments and Future Outlook
Table 6.17. LumaCyte: Key Highlights
Table 6.18. LumaCyte: Funding Instances
Table 6.19. LumaCyte: Key Characteristics of Radiance™
Table 6.20. LumaCyte: Recent Developments and Future Outlook
Table 6.21. Union Biometrica: Key Highlights
Table 6.22. Union Biometrica: Key Characteristics of COPAS™ FP and BioSorter®
Table 6.23. Union Biometrica: Recent Developments and Future Outlook
Table 6.24. LevitasBio: Key Highlights
Table 6.25. LevitasBio: Funding Instances
Table 6.26. LevitasBio: Key Characteristics of LeviCell System
Table 6.27. LevitasBio: Recent Developments and Future Outlook
Table 6.28. RareCyte®: Key Highlights
Table 6.29. RareCyte®: Funding Instances
Table 6.30. RareCyte®: Key Characteristics of AccuCyte® Sample Preparation System
Table 6.31. RareCyte®: Recent Developments and Future Outlook
Table 6.32. Cytonome: Key Highlights
Table 6.33. Cytonome: Key Characteristics of Cytonome Viva™, Cytonome Hydris™, Cytonome GigaSort™
Table 6.34. Cytonome: Recent Developments and Future Outlook
Table 6.35. Namocell: Key Highlights
Table 6.36. Namocell: Funding Instances
Table 6.37. Namocell: Key Characteristics of Namo™ Single Cell Dispenser and Hana™ Single Cell Dispenser
Table 6.38. Namocell: Recent Developments and Future Outlook
Table 7.1. STEMCELL Technologies: Key Highlights
Table 7.2. STEMCELL Technologies: Funding Instances
Table 7.3. STEMCELL Technologies: Product Portfolio
Table 7.4. STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.5. Akadeum Life Sciences: Key Highlights
Table 7.6. Akadeum Life Sciences: Funding Instances
Table 7.7. Akadeum Life Sciences: Product Portfolio
Table 7.8. Akadeum Life Sciences: Recent Developments and Future Outlook
Table 7.3. QIAGEN: Key Highlights
Table 7.10. QIAGEN: Funding Instances
Table 7.11. QIAGEN: Product Portfolio
Table 7.12. QIAGEN: Recent Developments and Future Outlook
Table 7.13. ScreenCell: Key Highlights
Table 7.14. ScreenCell: Product Portfolio
Table 7.15. ScreenCell: Recent Developments and Future Outlook
Table 7.16. RareCyte®: Product Portfolio
Table 8.1. Patent Analysis: CPC Symbol Definitions
Table 8.2. Patent Analysis: Most Popular CPC Symbols
Table 8.3. Patent Analysis: List of Top CPC Symbols
Table 8.4. Novel Cell Sorting Products and Solutions: Summary of Patent Benchmarking Analysis
Table 8.5. Novel Cell Sorting Products and Solutions: Categorizations based on Weighted Valuation Scores
Table 8.6. Leading Patents: Distribution by Relative Valuation
Table 8.7. Leading Patents: Distribution by Number of Citations
Table 10.1. Novel Cell Sorting Products and Solutions: List of Partnerships, 2014-Q1 2019
Table 10.2. Most Active Players: Geographical Distribution by Number of Partnerships
Table 11.1. Novel Cell Sorting Products and Solutions: List of Funding Instances, 2014-Q1 2019
Table 11.2. Novel Cell Sorting Products and Solutions: Summary of Investments
Table 14.1. Akadeum Life Sciences: Key Highlights
Table 14.2. LumaCyte: Key Highlights
Table 14.3. Namocell: Key Highlights
Table 15.1. Novel Cell Sorting Products and Solutions: Key Takeaways
Table 16.1. Novel Cell Sorting Products and Solutions: Distribution by Type of Product
Table 16.2. Novel Cell Sorting Products and Solutions: Distribution by Cell Sorting Technology
Table 16.3. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
Table 16.4. Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
Table 16.5. Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
Table 16.6. Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
Table 16.7. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
Table 16.8. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
Table 16.9. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
Table 16.10. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
Table 16.11. Leading Developers: Distribution by Number of Products
Table 16.12. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
Table 16.13. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
Table 16.14. Competitiveness Analysis of Large Novel Cell Sorting Products and Solutions Providers
Table 16.15. Patent Analysis: Distribution by Type
Table 16.16. Patent Analysis: Cumulative Year-wise Trend, 2014-2018
Table 16.17. Patent Analysis: Distribution by Geographical Location
Table 16.18. Patent Analysis: Distribution by CPC Symbols (Top 20)
Table 16.19. Most Active Industry Players: Distribution by Number of Patents
Table 16.20. Most Active Non-Industry Players: Distribution by Number of Patents
Table 16.21. Patent Analysis: Benchmarking by Patent Characteristics
Table 16.22. Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
Table 16.23. Patent Analysis: Benchmarking by Number of International Patents
Table 16.24. Patent Analysis: Distribution by Patent Age, 2014-2018
Table 16.25. Patent Analysis: Distribution by Geography and Year of Publication, 2014-2018
Table 16.26. Patent Analysis: Distribution by Relative Valuation
Table 16.27. Publication Analysis: Cumulative Year-wise Trend, 2014-2018
Table 16.28. Publication Analysis: Distribution by Cell Sorting Technology
Table 16.29. Publication Analysis: Distribution by End Use / Application Area
Table 16.30. Publication Analysis: Distribution by Type of Cell
Table 16.31. Publication Analysis: Distribution by Target Disease Indication
Table 16.32. Publication Analysis: Distribution by Type of Organization Involved
Table 16.33. Most Active Players: Distribution by Number of Publications
Table 16.34. Most Active Players: Geographical Distribution by Number of Publications
Table 16.35. Key Journals: Distribution by Number of Publications
Table 16.36. Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
Table 16.37. Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.38. Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 16.39. Partnerships and Collaborations: Distribution by Partner’s Focus Area
Table 16.40. Partnerships and Collaborations: Distribution by Cell Sorting Technology
Table 16.41. Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
Table 16.42. Most Active Players: Distribution by Number of Partnerships
Table 16.43. Most Active Players: Geographical Distribution by Number of Partnerships
Table 16.44. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.45. Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
Table 16.46. Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
Table 16.47. Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
Table 16.48. Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
Table 16.49. Funding and Investments: Distribution by Type of Funding
Table 16.50. Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
Table 16.51. Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
Table 16.52. Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
Table 16.53. Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
Table 16.54. Most Active Players: Distribution by Number of Instances
Table 16.55. Most Active Players: Distribution by Capital Amount Raised (USD Million)
Table 16.56. Most Active Investors: Distribution by Number of Instances
Table 16.57. Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
Table 16.58. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Units)
Table 16.59. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Units)
Table 16.60. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.61. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.62. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030 (Million Units)
Table 16.63. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.64. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Units)
Table 16.65. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Units)
Table 16.66. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.67. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.68. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Table 16.69. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.70. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Units)
Table 16.71. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Units)
Table 16.72. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.73. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.74. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Table 16.75. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.76. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Units)
Table 16.77. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Units)
Table 16.78. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
Table 16.79. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030 (Million Units)
Table 16.80. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
Table 16.81. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Units)
Table 16.82. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.83. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.84. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.85. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.86. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.87. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.88. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.89. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.90. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.91. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.92. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.93. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.94. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.95. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.96. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.97. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.98. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.99. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.100. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.101. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.102. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.103. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.104. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.105. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.106. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.107. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.108. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.109. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.110. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.111. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.112. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.113. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.114. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.115. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.116. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.117. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.118. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.119. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.120. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.121. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.122. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.123. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.124. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.125. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.126. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.127. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.128. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.129. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.130. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.131. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.132. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.133. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.134. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.135. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.136. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.137. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.138. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.139. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.140. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.141. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.142. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.143. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.144. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.145. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.146. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.147. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.148. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.149. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.150. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.151. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.152. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.153. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.154. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.155. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.156. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.157. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.158. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.159. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.160. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.161. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.162. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.163. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.164. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.165. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.166. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.167. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.168. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.169. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.170. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.171. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.172. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.173. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.174. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.175. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.176. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.177. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.178. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.179. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.180. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.181. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.182. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.183. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.184. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.185. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.186. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.187. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.188. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.189. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.190. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.191. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.192. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.193. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.194. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.195. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.196. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.197. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.198. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.199. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.200. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.201. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.202. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.203. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.204. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.205. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.206. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.207. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.208. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.209. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.210. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.211. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.212. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.213. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.214. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.215. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.216. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.217. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.218. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.219. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.220. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.221. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.222. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.223. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.224. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.225. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.226. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.227. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.228. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.229. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.230. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.231. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.232. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.233. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.234. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.235. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.236. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.237. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.238. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.239. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.240. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.241. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.242. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.243. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.244. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.245. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.246. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.247. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.248. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.249. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.250. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.251. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.252. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.253. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.254. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.255. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.256. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.257. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.258. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.259. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.260. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.261. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.262. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.263. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.264. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.265. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.266. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.267. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.268. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.269. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.270. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 16.271. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.272. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.273. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.274. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.275. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.276. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.277. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.278. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.279. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.280. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.281. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.282. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.283. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.284. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
Table 16.285. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)

Executive Summary

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of novel cell sorting and separation market in the mid-long term.

Chapter 3 is an introductory chapter that presents a general overview of cell sorting and separation, including a brief history of development, and information on the basic components and principle of operation of a cell sorter. Further, it features a detailed discussion on conventional cell separation techniques and the various challenges associated with their use across different application areas. The chapter also includes detailed sections on the novel cell sorting and separation technologies (such as acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), highlighting their advantages and challenges. Further, it features a discussion on the key growth drivers and roadblocks related to modern cell sorting technologies, as well as upcoming trends that the field is expected to witness in the coming years.

Chapter 4 includes information on more than 200 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with details on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics). The chapter also highlights the contributions of various companies engaged in this domain, presenting detailed analyses, based on their year of establishment, size of employee base, geographical presence, and type of offering.

Chapter 5 features an insightful competitiveness analysis of the companies engaged in novel cell sorting and separation domain, based on various parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s). In the chapter, stakeholder entities have been plotted on a 2X2 matrix, featuring a company’s Supplier Power (based on size of employee base and experience in this segment of the industry) and Company Competitiveness as the two axes.

Chapter 6 includes elaborate profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel cell sorters / sorting technologies; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 7 includes detailed profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel consumables and cell isolation kits; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 8 provides an in-depth patent analysis to provide an overview of how the industry is evolving from the R&D perspective. For this analysis, we considered those patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. The analysis also highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.

Chapter 9 presents a detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analyses based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain.

Chapter 10 features an elaborate analysis and discussion of partnerships / collaborations that have been established in this domain in the period 2014-Q1 2019. It includes a brief description of various types of partnership models (such as R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and others) that have been employed by stakeholders within this domain. It also consists of a schematic representation showcasing the players that have established the maximum number of alliances related to novel cell sorting and separation technologies. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 11 provides information on funding instances and investments that have been made within the novel cell sorting and separation domain. The chapter includes details on various types of investments (such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings) received by companies in the period 2014-Q1 2019, highlighting the growing interest of the venture capital community and other strategic investors in this domain.

Chapter 12 provides an overview of the demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in the contemporary market. In order to estimate the aforementioned demand, we considered the number of ongoing / completed research studies, diagnostic tests and cell-based therapies under development across different geographies. We also estimated the likely adoption of such products and solutions across key application areas, over the period 2019-2030.

Chapter 13 features a comprehensive market forecast, highlighting the future potential of novel cell sorting and separation market till 2030, based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing. In addition, we estimated the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 µm, 5-10 µm, 10-15 µm, 15-25 µm, and > 25 µm), and [G] key geographical regions (North America, Europe and Asia-Pacific). We adopted a bottom up approach, backed by robust data and credible inputs from primary research, to estimate the likely size of the market, both in terms of value (USD billion) and volume (number of products).

Chapter 14 is a collection of executive insights of the discussions that were held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences), Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte), and Soohee Cho (Product Manager, Namocell).

Chapter 15 is a summary of the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 16 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix, which contains the list of companies and organizations mentioned in the report.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

1087systems
48Hour Discovery
5AM Ventures
Abbott
AbbVie
Academia Sinica
Academic Medical Centre
Academy of Military Medical Sciences
Accelerate Diagnostics
ACEA Biosciences
AcouSort
Active Biotech
Adaptive Biotechnologies
Adelaide Research & Innovation
AdnaGen
ADS BIOTEC
Advanced Virus Detection Technologies Interest Group
Aegea Biotechnologies
Aenitis Technologies
Agency for Science, Technology and Research
Agilent Technologies
AIM Group International
AIMM Therapeutics
Akadeum Life Sciences
Albert Einstein College of Medicine
Alder BioPharmaceuticalss
Alexion Pharmaceuticals
Alkem Laboratories
Amazentis
Ambergen
American Institute of Health
Amgen
AnaptysBio
Ancera
Angel HQ
Angel Round Capital Fund
ANGLE
Ann & Robert H Lurie Children's Hospital of Chicago
ANSYS
Anzu Partners
ApoCell
Argonaut Manufacturing Services
arivis
Artiman Ventures
Ascent Bio-Nano Technologies
Ascus Biosciences
Astellas Pharma
Augusta University
Aurora Life Technologies
AVIVA Biosciences
Barts Cancer Institute
Base4 Innovation
Bay City Capital
Bayer
BC Cancer Agency
Beckman Coulter
Becton Dickinson
Beijing Genomics Institute
Beth Israel Deaconess Medical Center
Betta Pharmaceuticals
BGI Group
Biocept
Bioceptive
BioCrine
BioFluidica
BioInfleXion Point Partners
BIOKÉ
Biolidics
BioMEMS Resource Center
BioMimetic Therapeutics
Bio-Rad Laboratories
BIOSS
Bio-Techne
BioTheranostics
BioView
Boehringer Ingelheim
Boyalife Group
Bpifrance
Brigham and Women's Hospital
Bristol-Myers Squibb
Broad Institute
Bucher Biotec
C4 Therapeutics
California Institute of Technology
California NanoSystems Institute
Caltag Medsystems
Cambridge Consultants
Cambridge Enterprise
Canary Center at Stanford
Cancer Genetics
Cancer Institute of Greenville Health System
Cancer Metastasis Laboratory, University of Basel
Cancer Research UK Manchester Institute
CANCER-ID
Canon US Life Sciences
Capio Biosciences
Caris Life Sciences
Carnegie Mellon University
Case Western Reserve University
Catalyst Biosciences
Celgene
Cell Microsystems
Cell Signaling Technology
Cell.Copedia
Cellaviva
CellectCell
Cellenion
Cellix
CellMax Life
Celsee
Center for Advanced Medical Products
Centre Léon Bérard
Cephalon
Cesca Therapeutics
CFD Research
Chang Gung Memorial Hospital
ChemoCentryx
Chinese Academy of Medical Sciences
Cincinnati Children's Hospital Medical Center
Cipla
Clinomics
Columbia University
Cornell University
Corning
Creative BioArray
Creative Diagnostics
CREST
CRV International
CureGene
Cytonome
CytoVale
Cytovance Biologics
Dana-Farber Cancer Institute
Danaher
DAON BioSciences
Decheng Capital
Department of Biomedical Engineering, Lund University
Detroit Innovate
DiaSorin
Diffusion Capital Partners
Draper Laboratory
Duke University
eFFECTOR Therapeutics
Eisai
EKF Diagnostics
eLab Ventures
Eli Lilly
EMV Capital
Engender Technologies
Enlivex Therapeutics
Enterprise Angels
Epic Sciences
Evercyte
EXONBio
Fiona Stanley Hospital
Five3 Genomics
FloDesign Sonics
Florida Cancer Specialists and Research Institute
Fluidigm
France Innovation Scientifique et Transfert
French National Center for Scientific Research
Fudan University Shanghai Cancer Center
FusionX Ventures
GE Healthcare
GenapSys
Genentech
General Automation Lab Technologies
Genewiz
Genial Laboratory Automation
Genoa Ventures
Georgetown University
Georgia Tech Research Institute
Gilead Sciences
GILUPI
Glass Capital Management
GlaxoSmithKline
Glenmark Pharmaceuticals
GOM
Grace Bio-Labs
Greenwoods Asset Management
GRI Bio
Guangxi Academy of Sciences
Hahn-Schickard
Halcyon Biomedical
Halozyme Therapeutics
Harvard Stem Cell Institute
Harvard University
Horizon Discovery
Hubei Cancer Clinical Study Center
Humacyte
Humanitas Research Hospital
Hunan Agen Medicine Laboratory Technology
IBA Lifesciences
Icahn School of Medicine
ICE Angels
iCellate
ICREA
Ignyta
Illumina Ventures
IMEC
immatics biotechnologies
Immunomedics
ImmunoQure
Inabata
Inbiomotion
IncellDx
IncoCell Tianjin
Incyte
Inguran
Innate Pharma
Innovate UK
Innovative Biochips
Innovative Micro Technology
Inova
Institute of Cancer Research, London
Institute of Organic Chemistry and Biochemistry
Instrumentation Laboratory
Intrinsic LifeSciences
Invention Science Fund
Invest Michigan
Invetech
iPS Portal
Janssen Biotech
Japan Science and Technology Agency
Jiulongpo District People's Hospital
Jiva Sciences
John Hopkins University
John Wayne Cancer Institute
Jonsson Comprehensive Cancer Center
Karolinska Institute
Kataoka
Katholieke Universiteit Leuven
Keswick Ventures
Kiyatec
Koek Biotechnology
Kymab
LabCorp
Landos Biopharma
Lawson Health Research Institute
Leica Biosystems
LevitasBio
LG Electronics
LIDE Biotech
Life Technologies
Livzon Pharmaceuticals
London Business Angels
LPATH
LumaCyte
Luminex
LungLifeAI
Lupin
Mackay Memorial Hospital
Massachusetts Institute of Technology
Mayo Clinic Foundation
MD Anderson Cancer Center
MDxK
Medigen Biotech
MeMed Diagnostics
Memorial Sloan Kettering Cancer Center
Menarini Silicon Biosystems
Merck
Metabiota
Microbix Biosystems
MicroMedicine
Middle East Technical University
Mikro Biyosistemler
Mikro Systems
Millennium Pharmaceuticals
MilliporeSigma
Miltenyi Biotec
Morehouse School of Medicine
Morphotek
Mumbai Angels
Namocell
NanoCellect Biomedical
Nanosphere
NanoTag Biotechnologies
National Cancer Centre Singapore
National Cancer Institute
National Center for Emerging and Zoonotic Infectious Diseases
National Center for Nanoscience and Technology
National Institute for Health Research
National Institute for Innovation in Manufacturing Biopharmaceuticals
National Institute of Drug Abuse
National Institute of General Medical Sciences
National Institutes of Health
National University Hospital
National University of Ireland Galway’s Regenerative Medicine Institute
National University of Singapore
Naval Research Laboratory
Nektar Therapeutics
NeoDiagnostix
NeuroVision Pharma
New York Upstate Cord Blood Bank
New Zealand Venture Investment Fund
Newable Private Investing
NextGem
Nodality
Northeastern University
Northwestern University
Novartis
Novo Nordisk
Ohio State Innovation Foundation
On-chip Biotechnologies
Oregon Health & Science University
Organovo
Ortho Clinical Diagnostics
Orthohealing Center Management
Osaka University Venture Capital
Owl biomedical
OYAK
Pacific Biosciences
Pacific Channel
Packers Sanitation Services
Parkwalk Advisors
Partec
Penn State Research Foundation
PerkinElmer
Pfizer
Pharmaxis
Philips
Phywe
pluriSelect Life Science
Purdue Research Foundation
Qiagen
Quad Technologies
Qventures
R&D Systems
RareCyte
Real Tech Fund
Regeneron Pharmaceuticals
Regionalt Cancercentrum Stockholm-Gotland
RIKEN Bioresource Research Center
Riverside’s Highlander Venture Fund
Roche
Roswell Park Comprehensive Cancer Center
Rowan University
Rush University Medical Center
Samsung Medical Center
Sandoz
Sanford Burnham Prebys Medical Discovery Institute
Scholar Rock
ScreenCell
Seoulin Bioscience
Sequenom
Sequenta
Seventure Partners
Severance Hospital
Shilps Sciences
Shriners Hospitals for Children
Singapore General Hospital
Singapore Immunology Network
Singapore-MIT Alliance for Research and Technology
Singh Molecular Medicine
Singular BIO
Sir Charles Gairdner Hospital
Siwa Therapeutics
Skåne University Hospital
Sloan Kettering Institute
Sony Biotechnology
Southampton General Hospital
Sphere Fluidics
SpheriTech
SRI International
Stand Up To Cancer
Stanford University
Stanford Women's Cancer Center
StemBioSys
Stempeutics Research
Stony Brook University
Streck
Sumitomo Dainippon Pharma
Sutter Health
Syllogistech
SynGen Biotech
Syno Capital
Sysmex
Takeda Pharmaceutical
Tan Tock Seng Hospital
Targeted Technology Fund
Technical University of Denmark
Telegraph Hill Partners
Texas Stem Cell
The Fourth People's Hospital of Chongqing
Theranosis Life Sciences
Thermo Fisher Scientific
ThermoGenesis
ThinkCyte
Tisch Cancer Institute
Tokai Pharmaceuticals
TOMY Digital Biology
TorpedoDx
Tracon Pharmaceuticals
Trinity College Dublin
TumorGenesis
Twist Bioscience
Tyme
UCB Biopharma
UCLA Medical Center
Union Biometrica
United States Army Medical Research Institute for Infectious Diseases
United States Environmental Protection Agency
University of British Columbia
University of California
University of Chicago
University of Edinburgh
University of Illinois at Urbana-Champaign
University of Iowa Research Foundation
University of Kansas
University of Maryland
University of Miami
University of Michigan
University of Missouri
University of North Carolina
University of Notre Dame
University of Oxford John Radcliffe Hospital
University of Pennsylvania
University of Southern California Norris Comprehensive Cancer Center
University of Texas
University of Utah
University of Virginia School of Medicine
Uppsala University
US Department of Veterans Affairs
Vancouver Prostate Centre
Vanderbilt University
Vegenics
VentureSouth
Vertical Venture Partners
Vortex Biosciences
VWR
Wako Pure Chemical Industries
Washington University
Wego Medical Systems
Whitehead Institute for Biomedical Research
Woods Hole Oceanographic Institution
Wright State University
Xcell Biosciences
Yale University
Zeiss
Zhongnan Hospital of Wuhan University
Zomedica Pharmaceuticals
Zurich Instruments
ZymoGenetics

Methodology

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4416EUR$4,499USD£3,692GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7851EUR$7,999USD£6,564GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15704EUR$15,999USD£13,128GBP

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Methodology

Related Topics

Related Reports

Cell Sorting Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Cell Sorting - Global Strategic Business Report

Cell Sorting Market by Technology, Offering, Application, End-User - Global Forecast 2025-2030

The Global Microfluidics Market 2025-2035

3D Cell Culture Market Size, Share & Trends Analysis Report by Technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), Application, End-use, Region, and Segment Forecasts, 2024-2030